New heart valve offers hope for patients too sick for surgery
NCT ID NCT06568003
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 31 times
Summary
This study tests a new device, the LuX-Valve Plus, for people with a severe leaky heart valve (tricuspid regurgitation) who cannot have open-heart surgery. The goal is to see if the device can safely reduce the leak and improve symptoms. Fifteen participants will be followed for 30 days to check for complications and valve function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION (TR) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Montefiore Medical Center
New York, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.